Emil M. deGoma, MD

Penn Heart and Vascular Medicine

Hospital of University of Pennsylvania

Board Eligible, Cardiovascular Disease

Board certified, Internal Medicine and Clinical Lipidology

Cardiology Fellowship and Internal Medicine Residency, Stanford University

Harvard Medical School 2003, Harvard College, Magna Cum Laude, 1997

Lawrenceville Prep School 1993, Master’s Cup

 

Publications

1.  deGoma EM, deGoma RL, Rader DJ. Beyond HDL-cholesterol levels: Evaluating HDL function as influenced by pharmacotherapy. J Am Coll Cardiol 2008.

 

2.  deGoma EM, Leeper NJ, Heidenreich PA. Clinical significance of HDL-cholesterol among patients with low LDL-cholesterol. J Am Coll Cardiol 2008.

 

3. Leeper NJ, Ardehali R, deGoma EM, Heidenreich PA. Statin use in patients with extremely low LDL-cholesterol levels is associated with improved survival. Circulation 2007;116:613-8.

 

4. Rockson SG, deGoma EM, Fonarow GC. Reinforcing a continuum of care: In-hospital initiation of long-term secondary prevention following acute coronary syndromes. Cardiovasc Drugs Ther 2007;21:375-88.

 

5. Rockson SG, deGoma EM. Chapter 17: Peripheral arterial disease. In: Toth PP, Gotto AM, Jr., editors. Comprehensive Management of High Risk Cardiovascular Patients. Informa Healthcare, New York 2006.

 

6. deGoma EM, Vagelos RH, Fowler MB, Ashley EA. Emerging therapies for the management of decompensated heart failure: From bench to bedside.
J Am Coll Cardiol 2006;48:2397-409.

 

7. deGoma EM, Leeper NJ, Heidenreich PA. Clinical significance of HDL-C levels among patients with LDL-C less than 60 mg/dl. AHA Scientific Sessions. Chicago, IL. November 15, 2006. Population Science Poster Competition Winner.